Tower Research Capital LLC (TRC) - AIM IMMUNOTECH INC ownership

AIM IMMUNOTECH INC's ticker is AIM and the CUSIP is 00901B105. A total of 39 filers reported holding AIM IMMUNOTECH INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of AIM IMMUNOTECH INC
ValueSharesWeighting
Q2 2024$9,970
+16.4%
26,728
+47.0%
0.00%
Q1 2024$8,565
+3.0%
18,183
-3.8%
0.00%
Q4 2023$8,314
+1879.5%
18,897
+1942.9%
0.00%
Q3 2023$420
-86.9%
925
-80.7%
0.00%
Q2 2023$3,206
+320500.0%
4,785
+157.4%
0.00%
Q1 2023$11,859
+824.9%
0.00%
Q4 2022$02010.0%0.00%
Q3 2022$02010.0%0.00%
Q2 2022$02010.0%0.00%
Q1 2022$0
-100.0%
201
-95.9%
0.00%
Q4 2021$4,000
-81.0%
4,872
-49.9%
0.00%
-100.0%
Q2 2021$21,000
-4.5%
9,733
-22.2%
0.00%0.0%
Q4 2020$22,00012,5130.00%
Other shareholders
AIM IMMUNOTECH INC shareholders Q4 2023
NameSharesValueWeighting ↓
XTX Topco Ltd 29,269$63,0000.02%
SeaCrest Wealth Management, LLC 43,563$94,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 246,000$529,0000.01%
Lehman & Derafelo Financial Resources LLC 11,100$24,0000.01%
WINTON GROUP Ltd 54,894$118,0000.01%
Traynor Capital Management, Inc. 11,777$24,0000.00%
SNS Financial Group, LLC 10,000$22,0000.00%
Community Bank, N.A. 13,226$28,0000.00%
Verition Fund Management LLC 108,000$232,0000.00%
Tower Research Capital LLC (TRC) 9,733$21,0000.00%
View complete list of AIM IMMUNOTECH INC shareholders